Skip to main content
. 2018 Sep 27;24:6832–6839. doi: 10.12659/MSM.909810

Figure 5.

Figure 5

Treatment with LDL and IL-1β activates the NLRP3 inflammasome in MPC5 cells via CD36. MPC5 cells were treated as indicated. Protein expression of NLRP3 (A) and caspase-1 activity (B) were determined by Western blotting and using a commercial kit, respectively. *, *** p<0.05 vs. CTR cells; **, **** p<0.05 vs. LDL+IL-1β-treated cells.